根据名称进行药物检索

Aceon与瑞士法郎

Aceon与瑞士法郎安全配伍检测的结果。

检测结果:

Aceon <> 瑞士法郎

现实性: 23.07.2019 评论家: 医学副博士Shkutko P.M., in

通过权威的信息来源 Drugs.com、Rxlist.com、Webmd.com、Medscape.com，在进行所选药物与这种伴发疾病互相作用检测时，发现一些会产生负面影响或对身体危害的禁忌症及副作用。

用户:

高手抑制剂可能造成标记的肾损伤病人的肾功能取决于活动的肾素血管紧张素醛固酮系统。此外，对症，有时过度低血压可能发生在易受影响的个人，特别是在开始治疗，这可能会影响肾脏、心肌灌注。在患有严重的充血性心力衰竭(瑞士法郎)，处理与高手抑制剂可能与尿少和/或逐步氮质血症，并很少，肾功能衰竭，心肌局部缺血和死亡。治疗与高手抑制剂应当发起在非常密切的医疗监督在患有严重的瑞士法郎，尤其是当伴随着体积和/或钠的耗尽。患者应该密切监视几个小时之后最初的剂量，直到血压力已经稳定，紧随其后的第2个星期的治疗并且每当剂量的王牌抑制剂或利尿增加。如果可行的，风险的严重低血压可能是最小化通过减少或暂时扣缴的配量的利尿剂和/或自由化的饮食钠的摄入量为2至3天前开始高手抑制剂的治疗。在病人的经验不断恶化的肾功能时，停止高手抑制剂治疗通常不要求提供有症状的改进心脏衰竭和肾恶化以容忍的。瞬态的低血压也不是一个禁忌，进一步处理与高手抑制剂。后血压稳定，治疗通常是可以恢复谨慎，虽然较低剂量的王牌抑制剂和/或剂量的减少或中止的同时给予的利尿剂可能是必要的。

来源

Moyses C, Higgins TJ "Safety of long-term use of lisinopril for congestive heart failure." Am J Cardiol 70 (1992): c91-7
"Product Information. Altace (ramipril)." Hoechst Marion-Roussel Inc, Kansas City, MO.
"Product Information. Lotensin (benazepril)." Ciba Pharmaceuticals, Summit, NJ.
Moyses C, Higgins TJ "Safety of long-term use of lisinopril for congestive heart failure." Am J Cardiol 70 (1992): c91-7
"Product Information. Capoten (captopril)." Bristol-Myers Squibb, Princeton, NJ.
Kober L, Torp-Pedersen C, Carlsen JE, Bagger H, Eliasen P, Lyngborg K, Videbaek J, Cole DS, Auclert L, Pauly NC, et al "A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group." N Engl J Med 333 (1995): 1670-6
"Product Information. Mavik (trandolapril)." Knoll Pharmaceutical Company, Whippany, NJ.
"Product Information. Vasotec (enalapril)." Merck & Co, Inc, West Point, PA.
Kostis JB, Shelton BJ, Yusuf S, Weiss MB, Capone RJ, Pepine CJ, Gosselin G, Delahaye F, Probstfield JL, Cahill L, Dutton D "Tolerability of enalapril initiation by patients with left ventricular dysfunction: results of the medication challenge phase of the studies of left ventricular dysfunction." Am Heart J 128 (1994): 358-64
Schwartz D, Averbuch M, Pines A, et al "Renal toxicity of enalapril in very elderly patients with progressive, severe congestive heart failure." Chest 100 (1991): 1558-61
"Product Information. Monopril (fosinopril)." Bristol-Myers Squibb, Princeton, NJ.
"Product Information. Accupril (quinapril)." Parke-Davis, Morris Plains, NJ.
"Product Information. Aceon (perindopril)." Solvay Pharmaceuticals Inc, Marietta, GA.
"Product Information. Prinivil (lisinopril)." Merck & Co, Inc, West Point, PA.
"Product Information. Univasc (moexipril)." Schwarz Pharma, Mequon, WI.
American Medical Association, Division of Drugs and Toxicology "Drug evaluations annual 1994." Chicago, IL: American Medical Association; (1994):
Kostis JB, Shelton B, Gosselin G, Goulet C, Hood WB, Kohn RM, Kubo SH, Schron E, Weiss MB, Willis PW, Young JB, Probstfie "Adverse effects of enalapril in the studies of left ventricular dysfunction (SOLVD)." Am Heart J 131 (1996): 350-5
Heintz B, Verho M, Brockmeier D, Kirsten R, Nelson K, Maigatter S, Lefevre G, Kierdorf H, Sieberth HG "Influence of ramipril on renal function in patients with chronic congestive heart failure." J Cardiovasc Pharmacol 18 (1991): s174-9
Antonios TFT, Macgregor GA "Angiotensin converting enzyme inhibitors in hypertension: potential problems." J Hypertens 13 Suppl (1995): s11-6
Dietz R, Nagel F, Osterziel KJ "Angiotensin-converting enzyme inhibitors and renal function in heart failure." Am J Cardiol 70 (1992): c119-25
Ljungman S, Kjekshus J, Swedberg K "Renal function in severe congestive heart failure during treatment with enalapril." Am J Cardiol 70 (1992): 479-87